Shanshan Jiang, Xiaolin Lin, Lekai Ni, Yanjie Zhang, Haoyan Chen, Chuan Liu et al. Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study. // Cancer Cell. – DOI: 10.1016/j.ccell.2026.10.012. – URL: https://www.sciencedirect.com/science/article/pii/S1535610826004782?dgcid=rss_sd_all
Shanshan Jiang, Xiaolin Lin, Lekai Ni, Yanjie Zhang, Haoyan Chen, Chuan Liu, Haihua Yuan, Ziran Kang, Jiali Jiao, Ting Han, Meng Zhuo, Xiuqi Wu, Jingyi Zhou, Rongze Sun, Muni Hu, Zhixing Deng, Yichao Jiang, Chenyi Zhang, Pingping Xu, Peiying Li, Qi Li, Ying-Xuan Chen, Xiu-Ying Xiao, & Jing-Yuan Fang Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.10.012
Shanshan Jiang, et al. “Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study.” Cancer Cell. doi:10.1016/j.ccell.2026.10.012.
@article{Jiang,
title = {Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study},
author = {Jiang, Shanshan and Lin, Xiaolin and Ni, Lekai and Zhang, Yanjie and Chen, Haoyan and Liu, Chuan and Yuan, Haihua and Kang, Ziran and Jiao, Jiali and Han, Ting and Zhuo, Meng and Wu, Xiuqi and Zhou, Jingyi and Sun, Rongze and Hu, Muni and Deng, Zhixing and Jiang, Yichao and Zhang, Chenyi and Xu, Pingping and Li, Peiying and Li, Qi and Chen, Ying-Xuan and Xiao, Xiu-Ying and Fang, Jing-Yuan},
journal = {Cancer Cell},
doi = {10.1016/j.ccell.2026.10.012},
url = {https://www.sciencedirect.com/science/article/pii/S1535610826004782?dgcid=rss_sd_all}
}